Smith Mark Douglas

Smith Mark Douglas is listed in filings as Director at Teladoc Health Inc. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Teladoc Health Inc (TDOC), Jazz Pharmaceuticals PLC (JAZZ), and Phreesia, Inc. (PHR) (PHR). The current snapshot covers public activity from Aug 6, 2024 to May 21, 2026. Reported amounts are shown as $200.8K to $33.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.